Year: 2017
Type: editorial
Abstract: Identification of candidate cancer therapeutic small molecule activators of the TRAIL gene was the primary goal that led to identification of TIC10 (later renamed as ONC201).1 Of >1000 molcules scr...
Source: Cell Cycle
Authors: Peter M. Anderson, Jacob Scott
Institution: Cleveland Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W2639017031